Targeting siRNA in colorectal cancer therapy: Nanotechnology comes into view. Issue 9 (28th March 2019)

• Record Type: Journal Article
• Authors: Aghamiri, Shahin; Jafarpour, Ali; Malekshahi, Ziba Veisi; Mahmoudi Gomari, Mohammad; Negahdari, Babak
• Is Part Of: Journal of cellular physiology. Volume 234:Issue 9(2019:Sep.)
• Page Start: 14818
• Page End: 14827
• Publication Date: 2019-03-28
• Subjects: colorectal cancer -- nanoparticle -- nanotechnology -- RNA interference -- siRNA nanoparticle; Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.28281
• Languages: English
• ISSNs: 0021-9541

Abstract

Abstract: Colorectal cancer (CRC) is known as one of the most important causes of death and mortality worldwide. Although several efforts have been made for finding new therapies, no achievements have been made in this area. Multidrug resistance (MDR) mechanisms are one of the key factors that could lead to the failure of chemotherapy. Moreover, it has been shown that various chemotherapy drugs are associated with several side effects. Hence, it seems that finding new drugs or new therapeutic platforms is required. Among different therapeutic approaches, utilization of nanoparticles (NPs) for targeting a variety of molecules such as siRNAs are associated with good results for the treatment of CRC. Targeting siRNA‐mediated NPs could turn off the effects of oncogenes and MDR‐related genes. In the current study, we summarized various siRNAs targeted by NPs which could be used for the treatment of CRC. Moreover, we highlighted other routes such as liposome for targeting siRNAs in CRC therapy.